SKL 10406
Alternative Names: SKL DEP; SKL-10406Latest Information Update: 11 Apr 2016
Price :
$50 *
At a glance
- Originator SK Holdings
- Developer SK biopharmaceuticals
- Class Antidepressants
- Mechanism of Action Adrenergic uptake inhibitors; Dopamine uptake inhibitors; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 03 Jul 2007 SK Bio-Pharmaceuticals is now called SK Drug Development Center